HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2007318165 (hide)

Owner Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Merck Sharp & Dohme Corp.

Inventors Petrocchi, Alessia; McCauley, John A.; Summa, Vincenzo; Harper, Steven; Pompei, Marco; Gilbert, Kevin F.; McIntyre, Charles J.; Rudd, Michael T.; Romano, Joseph J.; Ferrara, Marco; Di Francesco, Maria Emilia; Liverton, Nigel J.; Holloway, Katharine M.; Butcher, John W.

Agent Spruson & Ferguson

Pub. Number AU-B-2007318165

PCT Pub. Number WO2008/057209

Priority 60/854,912 27.10.06 US; 60/997,434 03.10.07 US

Filing date 23 October 2007

Wipo publication date 15 May 2008

Acceptance publication date 17 November 2011

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/12 (2006.01) - Ketones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/12 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/057209 Priority application(s): WO2008/057209

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.

17 November 2011 Application Accepted

  Published as AU-B-2007318165

15 March 2012 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318173-Spinal cross connectors

2007318164-HCV NS3 protease inhibitors